| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.4 |